Company Overview and News

9
TOTAL Buys G2mobility, Expands Vehicle Charging Businesses

2018-09-21 zacks
TOTAL S.A. (TOT - Free Report) announced that it has entered into an agreement to acquire G2mobility, a French leading provider of electric vehicle charging solutions. The deal will expand the company’s footprint in electric vehicle charging businesses, ranging from designing smart charging stations to optimizing energy usage management and selling integrated services. New Energies for Mobility Rapid urbanization and development of infrastructure are resulting in massive growth in the usage of vehicles across the globe.
SPWR CLNE 5GD SRGRF PMOIF PMO PMOIY

10
SunPower (SPWR) Catches Eye: Stock Jumps 5.3%

2018-09-20 zacks
SunPower Corporation (SPWR - Free Report) was a big mover last session, as the company saw its shares rise more than 5% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $6.37 to $7.55 in the past one-month time frame.
CNX.WI SPWR SIR 5GD SRGRF HAYN LB

9
Why SunPower Finally Looks Safe for Investors Again

2018-09-19 247wallst
SunPower Corp. (NASDAQ: SPWR) had been having a tough year, along with many other companies that are tied to solar energy. It seems that even in alternative energy nothing lasts forever. But Tuesday brought on large gains after SunPower said that several of its products were not going to be included in the U.S. tariffs.
SPWR 5GD SRGRF

9
Are Options Traders Betting on a Big Move in SunPower (SPWR) Stock?

2018-09-19 zacks
Investors in SunPower Corporation (SPWR - Free Report) need to pay close attention to the stock based on moves in the options market lately. That is because the Sep 21, 2018 $6.50 Call had some of the highest implied volatility of all equity options today. What is Implied Volatility? Implied volatility shows how much movement the market is expecting in the future. Options with high levels of implied volatility suggest that investors in the underlying stocks are expecting a big move in one direction or the other.
SPWR 5GD SRGRF

9
Made in Mexico good enough for SunPower to win tariff exemption

2018-09-19 theedgemarkets
(Sept 19): SunPower Corp, the second-biggest U.S. solar manufacturer, won’t have to pay import tariffs on the panels it makes in factories outside the country.
SPWR 5GD SRGRF RJD RJF

9
SunPower receives exemption from Trump tariffs, shares soar

2018-09-18 channelnewsasia
SunPower Corp on Tuesday said some of the solar cells and panels it produces overseas will be excluded from the Trump administration's 30 percent import tariffs, sending the company's shares up 15 percent.
FP SPWR 5GD SRGRF

9
SunPower receives exemption from Trump tariffs, shares soar

2018-09-18 reuters
(Reuters) - SunPower Corp (SPWR.O) on Tuesday said some of the solar cells and panels it produces overseas will be excluded from the Trump administration’s 30 percent import tariffs, sending the company’s shares up 15 percent.
FP SPWR 5GD SRGRF

41
Short Sellers Jump on One Solar, One Alt Energy Stock

2018-09-13 247wallst - 1
Short interest moves among solar and alternative energy stocks were mixed during the two-week reporting period that ended on August 31. Of the companies we watch, short interest rose on two of three solar stocks and rose on three of five alternative energy stocks. We’ve added fuel cell maker Bloom Energy to our watch list this week.
SPWR CLNE BE FCELB 5GD SRGRF PEIX FSLR CSIQ PLUG FCEL

17
SunPower Gains from Higher Residential & Commercial Demand

2018-09-07 zacks
We recently issued an updated research report on SunPower Corporation (SPWR - Free Report) , which designs, develops, manufactures, markets and sells high-performance solar electric power technology products, systems and services worldwide. We expect focus on enhancing product offerings and expanding footprint in global untapped markets to boost results for the company. What’s Driving SunPower? SunPower continues to witness growth in residential and commercial markets.
CCR WU SPWR NOG 5GD SRGRF FIVE

10
MarketWatch First Take: Don’t let the smoke distract from the Tesla fire

2018-09-07 marketwatch - 1
Abrupt departure of accounting officer is the real issue, not Elon Musk’s amateurish puff of weed
SPWR 5GD SRGRF

44
Short Sellers Search for Direction on Solar, Alt Energy Stocks

2018-08-27 247wallst - 4
Short interest moves among solar and alternative energy stocks were mixed during the two-week reporting period that ended on August 15. Of the companies we watch, short interest rose on two of three solar stocks and rose on two of four alternative energy stocks.
SPWR CLNE FCELB 5GD SRGRF PEIX FSLR CSIQ PLUG FCEL

19
Enphase Poised To Retrace As Analyst Day Reveals Disruptive Tech

2018-08-22 seekingalpha - 2
Buckle up, there's a lot to cover. For those of you who don't want to read to the end, here are the high points:
SQ SPWR 5GD SRGRF ETSY

12
US tariffs cast a cloud over Huawei's solar electronics launch

2018-08-21 theedgemarkets - 2
BENGALURU (Aug 21): Huawei Technology Co's coming US launch of a solar-panel control device is expected to collide with new Trump administration tariffs on Chinese electronics, undermining a product that analysts had seen as challenging rivals on pricing.
SPWR 5GD SRGRF ENPH

10
US tariffs cast a cloud over Huawei's solar electronics launch

2018-08-21 channelnewsasia
Huawei Technology Co's coming U.S. launch of a solar-panel control device is expected to collide with new Trump administration tariffs on Chinese electronics, undermining a product that analysts had seen as challenging rivals on pricing.
SPWR 5GD SRGRF ENPH

10
U.S. tariffs cast a cloud over Huawei's solar electronics launch

2018-08-21 reuters
(Reuters) - Huawei Technology Co’s coming U.S. launch of a solar-panel control device is expected to collide with new Trump administration tariffs on Chinese electronics, undermining a product that analysts had seen as challenging rivals on pricing.
SPWR 5GD SRGRF ENPH

Related Articles

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

EKSO: Ekso Bionics Holdings Analysis and Research Report

2018-09-18 - Asif

Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...

AGRX: Agile Therapeutics Analysis and Research Report

2018-09-18 - Asif

Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...